Point of Care Diagnostics

Point-of-Care-Testing (POCT) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical decisions to be made.

POCT will become the recommended testing/screening methodology from the over-burdened provincial healthcare agencies whereby the test will either be user/patient direct pay or done in the Doctor's office at a reduced cost to the healthcare provincial system. In the United States the POCT will be exclusively user/patient pay only.

NanoSpeed's first POCT product, called Test4D™, is a qualitative human Lateral Flow Immunoassay (LFIA) for 25-hydroxyvitamin D to be administered either at the POC site or at home by the medical professionals.

Learn More


Lab on a Chip

To expand our Test4™ (qualitative test) product line into a second generation Point-Of-Care (POC) product line, NanoSpeed is developing a state-of-the-art technology platform based on microfluidic test chips and hand-held fluorescence reader technology. Our Lab-On-a-Chip (LOC) product line will perform rapid quantitative POC analysis of clinical samples. Our LOC chips are just a few square centimeters in size. The features of our LOC chip will be microfluidic flow manipulation of several nano-molecules, separation and isolation of analytes, analyte immobilization, specific detection functionalities, and the capability of handling extremely low fluid volumes down to a few micro liters. Detection is performed either by direct fluorescence or through immunoassay techniques.

The unique easy-to-use design and configuration allows for nutritional and clinical analysis/diagnosis within minutes in research laboratories, hospitals, and physician clinics, as well as in the field and on remote sites. The low cost of our disposable LOC chips permits cost-effective testing and makes quantitative analysis available to a broad population in a wide spectrum of applications.

Learn More

About NanoSpeed Diagnostics Inc.

Our Vision:

The immediate delivery of crucial personal health information, thus empowering our clients to quickly make critical decisions to benefit their well-being.

Our Mission Statement:

Nanospeed Diagnostics Inc. strives to be a recognized global leader focused on providing portable, innovative and rapid testing solutions, with substantive value, to existing and for emerging client needs in the healthcare and industry sectors.

News & Events

NanoSpeed reaches sales of one million

NanoSpeed Diagnostics and Test4Dâ„¢ achieves major sales milestone

NanoSpeed Diagnostics Inc. is pleased to announce that Test4D™, the world's first point-of-care test for vitamin D sufficiency, has reached sales of one million (1,000,000) tests since the product launch in 2013.

Dynalife Dx

NanoSpeed Diagnostics enters into Research Collaboration with Dynalife Dx

NanoSpeed Diagnostics Inc. ("NanoSpeed") is pleased to announce a new multi-year research collaboration with Dynalife Dx Inc. ("Dynalife") to develop new point of care tests to help patients obtain faster information on their own health.

2015 AACC Annual Meeting and Clinical Lab Expo

NanoSpeed Diagnostics Inc. to participate in the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo

NanoSpeed Diagnostics Inc. will participate in the 2015 AACC Annual Meeting and Clinical Lab Expo. The event takes place from July 26-July 30, 2015 at the Georgia World Congress Center in Atlanta, Georgia.